These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Alphaviruses as tools in neurobiology and gene therapy. Lundstrom K J Recept Signal Transduct Res; 1999; 19(1-4):673-86. PubMed ID: 10071792 [TBL] [Abstract][Full Text] [Related]
25. Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo. Lingor P; Schöll U; Bähr M; Kügler S Exp Brain Res; 2005 Mar; 161(3):335-42. PubMed ID: 15502982 [TBL] [Abstract][Full Text] [Related]
26. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Ehrengruber MU; Hennou S; Büeler H; Naim HY; Déglon N; Lundstrom K Mol Cell Neurosci; 2001 May; 17(5):855-71. PubMed ID: 11358483 [TBL] [Abstract][Full Text] [Related]
27. Functional defects of RNA-negative temperature-sensitive mutants of Sindbis and Semliki Forest viruses. Keränen S; Kääriäinen L J Virol; 1979 Oct; 32(1):19-29. PubMed ID: 541824 [TBL] [Abstract][Full Text] [Related]
28. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. Zhang J; Frolov I; Russell SJ J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589 [TBL] [Abstract][Full Text] [Related]
29. Novel mutant Semliki Forest virus vectors: gene expression and localization studies in neuronal cells. Lundstrom K; Rotmann D; Hermann D; Schneider EM; Ehrengruber MU Histochem Cell Biol; 2001 Jan; 115(1):83-91. PubMed ID: 11219612 [TBL] [Abstract][Full Text] [Related]
31. Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Ventoso I; Sanz MA; Molina S; Berlanga JJ; Carrasco L; Esteban M Genes Dev; 2006 Jan; 20(1):87-100. PubMed ID: 16391235 [TBL] [Abstract][Full Text] [Related]
33. Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability. Casales E; Rodriguez-Madoz JR; Ruiz-Guillen M; Razquin N; Cuevas Y; Prieto J; Smerdou C Virology; 2008 Jun; 376(1):242-51. PubMed ID: 18442838 [TBL] [Abstract][Full Text] [Related]
34. Neurons and oligodendrocytes in the mouse brain differ in their ability to replicate Semliki Forest virus. Fragkoudis R; Tamberg N; Siu R; Kiiver K; Kohl A; Merits A; Fazakerley JK J Neurovirol; 2009 Jan; 15(1):57-70. PubMed ID: 19115134 [TBL] [Abstract][Full Text] [Related]
35. CNS gene therapy applications of the Semliki Forest virus 1 vector are limited by neurotoxicity. Graham A; Walker R; Baird P; Hahn CN; Fazakerley JK Mol Ther; 2006 Mar; 13(3):631-5. PubMed ID: 16423561 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts. Kim KH; Rümenapf T; Strauss EG; Strauss JH Virology; 2004 May; 323(1):153-63. PubMed ID: 15165827 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the structural properties of Sindbis and Semliki forest virus nucleocapsids. Söderlund H; von Bonsdorff CH; Ulmanen I J Gen Virol; 1979 Oct; 45(1):15-26. PubMed ID: 118237 [TBL] [Abstract][Full Text] [Related]
38. Growth and stability of a cholesterol-independent Semliki Forest virus mutant in mosquitoes. Ahn A; Schoepp RJ; Sternberg D; Kielian M Virology; 1999 Sep; 262(2):452-6. PubMed ID: 10502523 [TBL] [Abstract][Full Text] [Related]
39. Semliki Forest virus (SFV) vectors in neurobiology and gene therapy. Lundstrom K; Ehrengruber MU Methods Mol Med; 2003; 76():503-23. PubMed ID: 12526182 [No Abstract] [Full Text] [Related]